{"<h3>Importance</h3>": [0], "Short-term": [1], "and": [2, 17, 29, 38, 47, 65, 85, 96, 107, 116, 147, 151, 165, 168, 177, 214, 260, 283, 285, 316, 334, 337, 341, 369, 391], "long-term": [3, 374], "persistent": [4], "postacute": [5], "sequelae": [6], "of": [7, 19, 35, 49, 78, 137, 184, 194, 203, 233, 350], "COVID-19": [8, 195, 234, 351], "(PASC)": [9], "have": [10], "not": [11], "been": [12], "systematically": [13], "evaluated.": [14], "The": [15, 100, 132, 199, 229, 359], "incidence": [16], "evolution": [18, 48], "PASC": [20, 93, 138, 153, 240, 354, 362, 375], "are": [21], "dependent": [22], "on": [23, 62, 92, 378], "time": [24], "from": [25, 70, 83], "infection,": [26], "organ": [27, 44, 157], "systems": [28], "tissue": [30], "affected,": [31], "vaccination": [32], "status,": [33], "variant": [34], "the": [36, 56, 126], "virus,": [37], "geographic": [39], "region.": [40], "<h3>Objective</h3>": [41], "To": [42], "estimate": [43], "system\u2013specific": [45], "frequency": [46, 136], "PASC.": [50], "<h3>Evidence": [51], "Review</h3>": [52], "PubMed": [53], "(MEDLINE),": [54], "Scopus,": [55], "World": [57], "Health": [58], "Organization": [59], "Global": [60], "Literature": [61], "Coronavirus": [63], "Disease,": [64], "CoronaCentral": [66], "databases": [67, 84], "were": [68, 81, 98, 114, 154, 212, 218, 288], "searched": [69], "December": [71], "2019": [72], "through": [73, 86], "March": [74], "2021.": [75], "A": [76], "total": [77, 183], "2100": [79, 185], "studies": [80, 186, 189, 227], "identified": [82], "cited": [87], "references.": [88], "Studies": [89], "providing": [90], "data": [91, 113], "in": [94, 389], "children": [95], "adults": [97], "included.": [99], "Preferred": [101], "Reporting": [102], "Items": [103], "for": [104, 111, 129], "Systematic": [105], "Reviews": [106], "Meta-analyses": [108], "(PRISMA)": [109], "guidelines": [110], "abstracting": [112], "followed": [115], "performed": [117], "independently": [118], "by": [119, 140, 156], "2": [120, 255], "reviewers.": [121], "Quality": [122], "was": [123, 135, 205, 241], "assessed": [124], "using": [125], "Newcastle-Ottawa": [127], "Scale": [128], "cohort": [130], "studies.": [131], "main": [133], "outcome": [134], "diagnosed": [139], "(1)": [141], "laboratory": [142], "investigation,": [143], "(2)": [144], "radiologic": [145], "pathology,": [146], "(3)": [148], "clinical": [149], "signs": [150], "symptoms.": [152], "classified": [155], "system,": [158], "ie,": [159], "neurologic;": [160], "cardiovascular;": [161], "respiratory;": [162], "digestive;": [163], "dermatologic;": [164], "ear,": [166, 335], "nose,": [167, 336], "throat": [169, 338], "as": [170, 172], "well": [171], "mental": [173, 277, 370], "health,": [174], "constitutional": [175, 286], "symptoms,": [176], "functional": [178, 280, 310, 364], "mobility.": [179], "<h3>Findings</h3>": [180], "From": [181], "a": [182, 379], "identified,": [187], "57": [188], "with": [190], "250": [191], "351": [192], "survivors": [193, 204, 235, 352], "met": [196], "inclusion": [197], "criteria.": [198], "mean": [200], "(SD)": [201], "age": [202], "54.4": [206], "(8.9)": [207], "years,": [208], "140": [209], "196": [210], "(56%)": [211], "male,": [213], "197": [215], "777": [216], "(79%)": [217], "hospitalized": [219], "during": [220], "acute": [221], "COVID-19.": [222], "High-income": [223], "countries": [224], "contributed": [225], "45": [226], "(79%).": [228], "median": [230], "(IQR)": [231], "proportion": [232], "experiencing": [236], "at": [237, 246, 254, 265], "least": [238], "1": [239, 247], "54.0%": [242, 261], "(45.0%-69.0%;": [243], "13": [244], "studies)": [245, 253, 264], "month": [248], "(short-term),": [249], "55.0%": [250], "(34.8%-65.5%;": [251], "38": [252], "to": [256], "5": [257], "months": [258, 269, 356], "(intermediate-term),": [259], "(31.0%-67.0%;": [262], "9": [263], "6": [266, 355], "or": [267, 318], "more": [268, 347], "(long-term).": [270], "Most": [271], "prevalent": [272], "pulmonary": [273, 367], "sequelae,": [274], "neurologic": [275], "disorders,": [276, 279], "health": [278, 371, 385], "mobility": [281, 365], "impairments,": [282, 366], "general": [284, 309], "symptoms": [287, 329], "chest": [289], "imaging": [290], "abnormality": [291], "(median": [292, 298, 305, 312, 321], "[IQR],": [293, 299, 306, 313, 322], "62.2%": [294], "[45.8%-76.5%]),": [295], "difficulty": [296], "concentrating": [297], "23.8%": [300], "[20.4%-25.9%]),": [301], "generalized": [302], "anxiety": [303], "disorder": [304], "29.6%": [307], "[14.0%-44.0%]),": [308], "impairments": [311], "44.0%": [314], "[23.4%-62.6%]),": [315], "fatigue": [317], "muscle": [319], "weakness": [320], "37.5%": [323], "[25.4%-54.5%]),": [324], "respectively.": [325], "Other": [326], "frequently": [327], "reported": [328], "included": [330], "cardiac,": [331], "dermatologic,": [332], "digestive,": [333], "disorders.": [339, 372], "<h3>Conclusions": [340], "Relevance</h3>": [342], "In": [343], "this": [344], "systematic": [345], "review,": [346], "than": [348], "half": [349], "experienced": [353], "after": [357], "recovery.": [358], "most": [360], "common": [361], "involved": [363], "abnormalities,": [368], "These": [373], "effects": [376], "occur": [377], "scale": [380], "that": [381], "could": [382], "overwhelm": [383], "existing": [384], "care": [386], "capacity,": [387], "particularly": [388], "low-": [390], "middle-income": [392], "countries.": [393]}